Ricketts SA - Search Results

1

MEDI3617, a human anti-angiopoietin 2 monoclonal antibody, inhibits angiogenesis and tumor growth in human tumor xenograft models.

Leow CC, Coffman K, Inigo I, Breen S, Czapiga M, Soukharev S, Gingles N, Peterson N, Fazenbaker C, Woods R, Jallal B, Ricketts SA, Lavallee T, Coats S, Chang Y. Leow CC, et al. Among authors: ricketts sa. Int J Oncol. 2012 May;40(5):1321-30. doi: 10.3892/ijo.2012.1366. Epub 2012 Feb 10. Int J Oncol. 2012. PMID: 22327175

2

Dual IGF-I/II-neutralizing antibody MEDI-573 potently inhibits IGF signaling and tumor growth.

Gao J, Chesebrough JW, Cartlidge SA, Ricketts SA, Incognito L, Veldman-Jones M, Blakey DC, Tabrizi M, Jallal B, Trail PA, Coats S, Bosslet K, Chang YS. Gao J, et al. Among authors: ricketts sa. Cancer Res. 2011 Feb 1;71(3):1029-40. doi: 10.1158/0008-5472.CAN-10-2274. Epub 2011 Jan 18. Cancer Res. 2011. PMID: 21245093

3

An evaluation of 2-deoxy-2-[18F]fluoro-D-glucose and 3'-deoxy-3'-[18F]-fluorothymidine uptake in human tumor xenograft models.

Keen H, Pichler B, Kukuk D, Duchamp O, Raguin O, Shannon A, Whalley N, Jacobs V, Bales J, Gingles N, Ricketts SA, Wedge SR. Keen H, et al. Among authors: ricketts sa. Mol Imaging Biol. 2012 Jun;14(3):355-65. doi: 10.1007/s11307-011-0504-4. Mol Imaging Biol. 2012. PMID: 21761255

4

Preclinical pharmacology of AZD5363, an inhibitor of AKT: pharmacodynamics, antitumor activity, and correlation of monotherapy activity with genetic background.

Davies BR, Greenwood H, Dudley P, Crafter C, Yu DH, Zhang J, Li J, Gao B, Ji Q, Maynard J, Ricketts SA, Cross D, Cosulich S, Chresta CC, Page K, Yates J, Lane C, Watson R, Luke R, Ogilvie D, Pass M. Davies BR, et al. Among authors: ricketts sa. Mol Cancer Ther. 2012 Apr;11(4):873-87. doi: 10.1158/1535-7163.MCT-11-0824-T. Epub 2012 Jan 31. Mol Cancer Ther. 2012. PMID: 22294718 Clinical Trial.

5

Micro-CT imaging of tumor angiogenesis: quantitative measures describing micromorphology and vascularization.

Ehling J, Theek B, Gremse F, Baetke S, Möckel D, Maynard J, Ricketts SA, Grüll H, Neeman M, Knuechel R, Lederle W, Kiessling F, Lammers T. Ehling J, et al. Among authors: ricketts sa. Am J Pathol. 2014 Feb;184(2):431-41. doi: 10.1016/j.ajpath.2013.10.014. Epub 2013 Nov 18. Am J Pathol. 2014. PMID: 24262753 Free PMC article.

6

2-Deoxy-2-[18F]fluoro-D-glucose positron emission tomography demonstrates target inhibition with the potential to predict anti-tumour activity following treatment with the AKT inhibitor AZD5363.

Maynard J, Ricketts SA, Gendrin C, Dudley P, Davies BR. Maynard J, et al. Among authors: ricketts sa. Mol Imaging Biol. 2013 Aug;15(4):476-85. doi: 10.1007/s11307-013-0613-3. Mol Imaging Biol. 2013. PMID: 23344784

7

Examining changes in [18 F]FDG and [18 F]FLT uptake in U87-MG glioma xenografts as early response biomarkers to treatment with the dual mTOR1/2 inhibitor AZD8055.

Keen HG, Ricketts SA, Maynard J, Logie A, Odedra R, Shannon AM, Wedge SR, Guichard SM. Keen HG, et al. Among authors: ricketts sa. Mol Imaging Biol. 2014 Jun;16(3):421-30. doi: 10.1007/s11307-013-0705-0. Mol Imaging Biol. 2014. PMID: 24249640

8

Quantitative correlation at the molecular level of tumor response to docetaxel by multimodal diffusion-weighted magnetic resonance imaging and [¹⁸F]FDG/[¹⁸F]FLT positron emission tomography.

Honndorf VS, Schmidt H, Wehrl HF, Wiehr S, Ehrlichmann W, Quintanilla-Martinez L, Barjat H, Ricketts SA, Pichler BJ. Honndorf VS, et al. Among authors: ricketts sa. Mol Imaging. 2014;13. doi: 10.2310/7290.2014.00045. Mol Imaging. 2014. PMID: 25430886 Free article.

9

Use of a novel Arg-Gly-Asp radioligand, 18F-AH111585, to determine changes in tumor vascularity after antitumor therapy.

Morrison MS, Ricketts SA, Barnett J, Cuthbertson A, Tessier J, Wedge SR. Morrison MS, et al. Among authors: ricketts sa. J Nucl Med. 2009 Jan;50(1):116-22. doi: 10.2967/jnumed.108.056077. Epub 2008 Dec 17. J Nucl Med. 2009. PMID: 19091899 Free article.

10

A longitudinal study assessing lens thickness changes in the eye of the growing beagle using ultrasound scanning: relevance to age of dogs in regulatory toxicology studies.

Maynard J, Sykes A, Powell H, Healing G, Scott M, Holmes A, Ricketts SA, Stewart J, Davis S. Maynard J, et al. Among authors: ricketts sa. J Appl Toxicol. 2014 Dec;34(12):1368-72. doi: 10.1002/jat.2967. Epub 2014 Jan 16. J Appl Toxicol. 2014. PMID: 24436247

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters